On August 28, 2026, Nature Medicine published the Phase 1 results from the COMPARE trial (NCT06475495), a Phase 1/2 study comparing B-cell depletion by rituximab and anti-CD19 CAR T cell therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results